Latest Press Releases

How Do You Obtain First Aid Certification

Accidents and emergencies can happen anywhere and at any time, from home to the workplace or even on the street. Knowing what to do in these situations can make a significant difference, and that’s where first aid training comes in. In 2022, there ...

How Long Does BLS Training Take to Complete?

When it comes to saving lives, BLS training is your first line of defense. Basic life support teaches you how to perform CPR, use an AED, and handle choking crises. Comprising basic information, video lectures, and hands-on practice with teachers, ...

Prytime Medical Announces First in European Use of New Extended Safe Occlusion Time Catheter

PR Newswire BOERNE, Texas, Jan. 7, 2025 BOERNE, Texas, Jan. 7, 2025 /PRNewswire/ -- Prytime Medical, The REBOA Company™, proudly announces the first civilian use of its pREBOA-PRO™ catheter in the European Union, following the device's ...

U.S. FDA Granted Priority Review to Dizal's Sunvozertinib New Drug Application

PR Newswire SHANGHAI, Jan. 7, 2025 SHANGHAI, Jan. 7, 2025 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced that the U.S. ...

Study Shows 90% of Persistent Lyme Patients Excluded from Clinical Trials

PR Newswire LOS ANGELES, Jan. 7, 2025 Research highlights need to expand PLD eligibility criteria to reflect real world data LOS ANGELES, Jan. 7, 2025 /PRNewswire/ -- Real-world data from the largest U.S. Lyme disease registry, ...

Vesper Bio initiates Phase Ib/IIa proof of concept study of VES001 in asymptomatic patients with gene mutations that cause frontotemporal dementia (FTD)

PR Newswire COPENHAGEN, Denmark, Jan. 7, 2025 COPENHAGEN, Denmark, Jan. 7, 2025 /PRNewswire/ -- Vesper Bio ApS ('Vesper' or 'the Company'), a clinical stage biotech and world leader in sortilin receptor biology, today announces the ...

BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease

PR Newswire PORTO, Portugal, Jan. 7, 2025 PORTO, Portugal, Jan. 7, 2025 /PRNewswire/ -- BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has ...

BerGenBio Announces First Patient Entered Into Advanced Adenocarcinoma Lung Cancer Trial

PR Newswire BERGEN, Norway, Jan. 7, 2025 BERGEN, Norway, Jan. 7, 2025 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing the novel, selective AXL kinase inhibitor bemcentinib for lung cancer ...

How Do You Obtain First Aid Certification

Accidents and emergencies can happen anywhere and at any time, from home to the workplace or even on the street. Knowing what to do in these situations can make a significant difference, and that’s where first aid training comes in. In 2022, there ...

How Long Does BLS Training Take to Complete?

When it comes to saving lives, BLS training is your first line of defense. Basic life support teaches you how to perform CPR, use an AED, and handle choking crises. Comprising basic information, video lectures, and hands-on practice with teachers, ...

NUS researchers boost chemotherapy uptake in breast cancer treatment with localised magnetic fields

PR Newswire SINGAPORE, Jan. 6, 2025 A recent study explained the mechanisms by which pulsed electromagnetic field therapy enhances doxorubicin uptake, paving the way for precision-driven cancer therapies with fewer side effects ...

Adcentrx Therapeutics Announces First Patient Dosed in the Phase 1a/b Study of ADRX-0405, a Potential First-in-Class ADC Targeting STEAP1 for the Treatment of Advanced Solid Tumors

PR Newswire SAN DIEGO, Jan. 6, 2025 SAN DIEGO, Jan. 6, 2025 /PRNewswire/ -- Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company advancing innovative protein conjugates for cancer and other life-threatening diseases, ...

Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma

PR Newswire LONDON, Jan. 7, 2025 Back to media releasesNext media release LONDON, Jan. 7, 2025 /PRNewswire/ -- Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) ...

Lumia Health™ Debuts World's First Wearable for Tracking Blood Flow to Your Head at CES 2025

PR Newswire BOSTON, Jan. 6, 2025 Clinically demonstrated wearable tracks blood flow to your head to help people with chronic illnesses better understand and self-manage symptoms caused by poor blood flow, now backed by $10.4M in funding and ...

KEVIN'S SONG 9TH ANNUAL CONFERENCE ON SUICIDE: CREATING & SUPPORTING LIVES WORTH LIVING

PR Newswire GROSSE POINTE FARMS, Mich., Jan. 6, 2025 Michigan's largest suicide prevention conference gathers leading experts to share advancements in suicide research, treatment, and prevention strategies GROSSE POINTE FARMS, Mich., ...

Introducing isaac by PreEvnt™ - Non-Invasive Blood Glucose Alert Device at the CES Digital Health Exhibit

PR Newswire OXNARD, Calif., Jan. 6, 2025 OXNARD, Calif., Jan. 6, 2025 /PRNewswire/ -- PreEvnt, a subsidiary of SCOSCHE Industries, a leading innovator of award-winning consumer technology will proudly unveil isaac* by PreEvnt at the Digital ...

Nemours Children's Health and State of Delaware to Launch First-of-its-Kind Payment Model for Children's Health

PR Newswire WILMINGTON, Del., Jan. 6, 2025 Agreement marks significant milestone in creating the healthiest generations of children WILMINGTON, Del., Jan. 6, 2025 /PRNewswire/ -- Nemours Children's Health and the State of Delaware today ...

Myant Acquires mmHg Inc. To Enhance Precision Medicine for Cardiovascular Care

PR Newswire TORONTO, Jan. 6, 2025 TORONTO, Jan. 6, 2025 /PRNewswire/ -- Myant Corp., a leader in chronic disease prevention through precision medicine, announced the acquisition of mmHg Inc., a digital health company specializing in remote ...

FDA Issues Draft Guidance on Including Tissue Biopsies in Clinical Trials

PR Newswire SILVER SPRING, Md., Jan. 6, 2025 SILVER SPRING, Md., Jan. 6, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration issued a draft guidance with the Office for Human Research Protections that, when finalized, will ...

VIV™ Ring: The World's 1st Smart Ring with Generative Sleep Aid Sound at CES 2025

PR Newswire LAS VEGAS, Jan. 6, 2025 LAS VEGAS, Jan. 6, 2025 /PRNewswire/ -- VIV Health is thrilled to announce the upcoming launch of the VIV™ Ring, the world's first smart ring equipped with Generative Sleep aid sound, at CES 2025, starting ...

FDA Issues Comprehensive Draft Guidance for Developers of Artificial Intelligence-Enabled Medical Devices

PR Newswire SILVER SPRING, Md., Jan. 6, 2025 Guidance Shares Strategies to Address Transparency and Bias, while Providing Key Considerations and Recommendations on Product Design, Development and Documentation SILVER SPRING, Md., Jan. 6, ...

Study Led by Phoenix Children's Shows Genetic Testing Can Change Care for Children with Cerebral Palsy

PR Newswire PHOENIX, Jan. 6, 2025 A genetic diagnosis can prevent complications and lead to precision treatments PHOENIX, Jan. 6, 2025 /PRNewswire/ -- According to a study published in JAMA Pediatrics, a peer-reviewed medical journal of ...

Baird Medical Sponsored and Showcased Advanced Microwave Ablation (MWA) Technology at the Sichuan Medical Association Thyroid Disease Conference

PR Newswire NEW YORK, Jan. 6, 2025 NEW YORK, Jan. 6, 2025 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a global leader in minimally invasive microwave ablation (MWA) technology, successfully sponsored and participated in the 4th Sichuan ...

Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI)

PR Newswire STATEN ISLAND, N.Y., Jan. 6, 2025 STATEN ISLAND, N.Y., Jan. 6, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company") is a late-stage biopharmaceutical company developing a new class of small ...

Nuclein Receives Dual FDA 510(k) Clearance and CLIA Waiver for DASH® SARS-CoV-2 & Flu A/B Test for use on the DASH® Rapid PCR System

PR Newswire AUSTIN, Texas, Jan. 6, 2025 Rapid PCR Made Simple™: DASH® Delivers Lab-Quality Results in 15 Minutes AUSTIN, Texas, Jan. 6, 2025 /PRNewswire/ -- Nuclein, a leader in rapid, point-of-care molecular diagnostics, today ...

Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 (Copper Histidinate) Product Candidate for Treatment of Menkes Disease

PR Newswire SOLANA BEACH, Calif. and AHMEDABAD, India and MIAMI, Jan. 6, 2025 Six-month priority review granted for CUTX-101 copper histidinate with PDUFA target action date set for June 30, 2025 CUTX-101 has potential to be the first ...

Bell Let's Talk's 15th annual day for mental health on January 22 to prioritize youth mental health crisis

Canada NewsWire MONTRÉAL, Jan. 6, 2025 MONTRÉAL, Jan. 6, 2025 /CNW/ - Bell Let's Talk Day kicks off its 15th year of action and change on January 22 by putting the spotlight on the growing youth mental health crisis. A first for Bell ...

CES 2025: Dianyx Innovations Reinvents Sleep Apnea Treatment and Concussion Monitoring with AI-Driven Oral Appliance

PR Newswire LAS VEGAS, Jan. 6, 2025 Creates New Revenue Opportunities for Medical Prescribers and Provides Continuous and Personalized Patient Data LAS VEGAS, Jan. 6, 2025 /PRNewswire-PRWeb/ -- Dianyx Innovations is set to make waves at ...

Radon is the Nation's 2nd Leading Cause of Lung Cancer; Lung Association Offers Tips to Safeguard Health in the New Year

PR Newswire CHICAGO, Jan. 6, 2025 January is National Radon Action Month; the American Lung Association urges every household to test for radon gas CHICAGO, Jan. 6, 2025 /PRNewswire/ -- Radon, a colorless, odorless and tasteless gas is ...

China's National Medical Products Administration (NMPA) Approves VYLOY™ (zolbetuximab) for First-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

PR Newswire TOKYO, Jan. 5, 2025 - China has the highest number of cases and deaths from gastric cancer of any country worldwide1 - - Zolbetuximab is the first and only therapy approved in China to target claudin 18.2, a biomarker ...

Vice-President of India Launches the Mobile Medical Clinic to Serve Remote Location with Aster Volunteers

Aster Volunteers, the global CSR (Corporate Social Responsibility) arm of Aster DM Healthcare, launched two IoT-enhanced Mobile Medical Clinics with Tele-Medicine Services to provide free medical care to underserved populations in Srinagar, Jammu & ...

KUDOS TO U.S. SURGEON GENERAL VIVEK MURTHY FOR RELEASING THE ALCOHOL AND CANCER RISK REPORT

PR Newswire SAN RAFAEL, Calif., Jan. 4, 2025 TAKE ACTION TO TELL THE TTB & CONGRESS TO REQUIRE CANCER WARNING LABELS ON ALL BEVERAGE ALCOHOL PRODUCTS SAN RAFAEL, Calif., Jan. 4, 2025 /PRNewswire/ -- Alcohol Justice is commending United ...

Latest Press Releases

Premium Press Releases »

How Do You Obtain First Aid Certification

How Long Does BLS Training Take to Complete?

Press Releases »

Prytime Medical Announces First in European Use of New Extended Safe Occlusion Time Catheter

U.S. FDA Granted Priority Review to Dizal's Sunvozertinib New Drug Application

Study Shows 90% of Persistent Lyme Patients Excluded from Clinical Trials

Vesper Bio initiates Phase Ib/IIa proof of concept study of VES001 in asymptomatic patients with gene mutations that cause frontotemporal dementia (FTD)

BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease

BerGenBio Announces First Patient Entered Into Advanced Adenocarcinoma Lung Cancer Trial

How Do You Obtain First Aid Certification

How Long Does BLS Training Take to Complete?

NUS researchers boost chemotherapy uptake in breast cancer treatment with localised magnetic fields

Adcentrx Therapeutics Announces First Patient Dosed in the Phase 1a/b Study of ADRX-0405, a Potential First-in-Class ADC Targeting STEAP1 for the Treatment of Advanced Solid Tumors

Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma

Lumia Health™ Debuts World's First Wearable for Tracking Blood Flow to Your Head at CES 2025

KEVIN'S SONG 9TH ANNUAL CONFERENCE ON SUICIDE: CREATING & SUPPORTING LIVES WORTH LIVING

Introducing isaac by PreEvnt™ - Non-Invasive Blood Glucose Alert Device at the CES Digital Health Exhibit

Nemours Children's Health and State of Delaware to Launch First-of-its-Kind Payment Model for Children's Health

Myant Acquires mmHg Inc. To Enhance Precision Medicine for Cardiovascular Care

FDA Issues Draft Guidance on Including Tissue Biopsies in Clinical Trials

VIV™ Ring: The World's 1st Smart Ring with Generative Sleep Aid Sound at CES 2025

FDA Issues Comprehensive Draft Guidance for Developers of Artificial Intelligence-Enabled Medical Devices

Study Led by Phoenix Children's Shows Genetic Testing Can Change Care for Children with Cerebral Palsy

Baird Medical Sponsored and Showcased Advanced Microwave Ablation (MWA) Technology at the Sichuan Medical Association Thyroid Disease Conference

Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI)

Nuclein Receives Dual FDA 510(k) Clearance and CLIA Waiver for DASH® SARS-CoV-2 & Flu A/B Test for use on the DASH® Rapid PCR System

Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 (Copper Histidinate) Product Candidate for Treatment of Menkes Disease

Bell Let's Talk's 15th annual day for mental health on January 22 to prioritize youth mental health crisis

CES 2025: Dianyx Innovations Reinvents Sleep Apnea Treatment and Concussion Monitoring with AI-Driven Oral Appliance

Radon is the Nation's 2nd Leading Cause of Lung Cancer; Lung Association Offers Tips to Safeguard Health in the New Year

China's National Medical Products Administration (NMPA) Approves VYLOY™ (zolbetuximab) for First-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Vice-President of India Launches the Mobile Medical Clinic to Serve Remote Location with Aster Volunteers

KUDOS TO U.S. SURGEON GENERAL VIVEK MURTHY FOR RELEASING THE ALCOHOL AND CANCER RISK REPORT

Medindia Newsletters